Search

everythinglearnresearchcommunity

for

Search:↓

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

Finasteride breakdown products found in bile and urine, helps understand drug safety and effectiveness.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Chemotherapy patients don't all lose their hair due to factors like hair growth rates, age, genetics, and the type of drugs used.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

HIF-1A may aid hair growth, Backhousia citriodora improves skin, autologous cells stabilize hair loss, infrared thermography assesses alopecia, and a new treatment preserves hair.

Thermal imaging is a useful non-invasive method to diagnose active inflammation in frontal fibrosing alopecia.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

Dutasteride and finasteride can help increase hair growth gene expression but need further improvement.

Certain types of mucopolysaccharidoses cause significant hair abnormalities.

Fat-derived stem cell therapies can potentially increase hair growth and thickness in people with hair loss.

Fat-derived stem cell therapies can potentially increase hair growth and thickness in people with hair loss.

Minoxidil helps grow longer, thicker hair in bald scalps of stumptailed macaques, and early treatment is more effective.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.